Recent News

CERIMED OBTAINS DUAL ISO 9001:2015 AND NF X50-900:2016 CERTIFICATION FOR ITS PRE-CLINICAL RADIOLOGICAL AND NUCLEAR SERVICE AND INNOVATION ACTIVITIES
On June 5, 2022, the European Center for Research in Medical Imaging (CERIMED, UMS AMU CNRS 2012) obtained dual ISO 9001:2015 and NF-X50-900 certification for its pre-clinical
Symposium’21 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”
Program here.
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility

Last Publications (10/268)

Frandon, J, Belaouni, A, Pellerin, O, Thiounn, N, Serrand, C, Droupy, S et al.. Efficacy and safety of prostate artery embolization for patients with lower urinary tract symptoms and indwelling urinary catheter: A retrospective multicenter study. Diagn Interv Imaging. 2022; :. doi: 10.1016/j.diii.2022.07.002. PubMed PMID:35963778 .
Tatiana, H, Elsa, K, Eric, G. [¹⁸F]FDG brain PET findings in CLIPPERS at diagnosis and therapeutic follow-up. Eur J Nucl Med Mol Imaging. 2022; :. doi: 10.1007/s00259-022-05939-x. PubMed PMID:35962144 .
Verger, A, Barthel, H, Tolboom, N, Fraioli, F, Cecchin, D, Albert, NL et al.. 2-[¹⁸F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee. Eur J Nucl Med Mol Imaging. 2022; :. doi: 10.1007/s00259-022-05913-7. PubMed PMID:35840817 PubMed Central PMC9286958.
Panneau, J, Mege, D, Biseglie, MD, Duclos, J, Habert, P, Vidal, V et al.. Emborrhoid: Rectal Artery Embolization for Hemorrhoid Disease. Semin Intervent Radiol. 2022;39 (2):194-202. doi: 10.1055/s-0042-1745800. PubMed PMID:35781988 PubMed Central PMC9246490.
Bec, R, Reynaud-Gaubert, M, Arnaud, F, Naud, R, Dufeu, N, Di Bisceglie, M et al.. Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: Early report. Eur J Radiol. 2022;154 :110421. doi: 10.1016/j.ejrad.2022.110421. PubMed PMID:35772339 .
Goren, S, Paladino, NC, Laks, S, Cuny, T, Vaillant-Lombard, J, Mennetrey, C et al.. Diagnostic Rechallenge with ¹⁸F-FCH PET/CT Often Allows Minimally Invasive Parathyroidectomy While Maintaining Exceptional Cure Rates. World J Surg. 2022; :. doi: 10.1007/s00268-022-06629-3. PubMed PMID:35763102 .
Nail, V, Louis, B, Moyon, A, Chabert, A, Balasse, L, Fernandez, S et al.. Sublingual Atropine Administration as a Tool to Decrease Salivary Glands’ PSMA-Ligand Uptake: A Preclinical Proof of Concept Study Using [⁶⁸Ga]Ga-PSMA-11. Pharmaceutics. 2022;14 (6):. doi: 10.3390/pharmaceutics14061276. PubMed PMID:35745848 PubMed Central PMC9230580.
Thiery, L, Carle, X, Testud, B, Boulouis, G, Habert, P, Tradi, F et al.. Distal cerebral vasospasm treatment following aneurysmal subarachnoid hemorrhage using the Comaneci device: technical feasibility and single-center preliminary results. J Neurointerv Surg. 2022; :. doi: 10.1136/neurintsurg-2022-018699. PubMed PMID:35584908 .
Soncin, LD, Faure, S, McGonigal, A, Horowitz, T, Belquaid, S, Bartolomei, F et al.. Correlation between fluorodeoxyglucose positron emission tomography brain hypometabolism and posttraumatic stress disorder symptoms in temporal lobe epilepsy. Epilepsia. 2022;63 (7):e74-e79. doi: 10.1111/epi.17300. PubMed PMID:35569022 .
Habert, P, Puech, B, Coiffard, B, Secq, V, Thomas, P, Bec, R et al.. Angiographic and histopathological study on bronchial-to-pulmonary vascular anastomoses on explants from patients with cystic fibrosis after bronchial artery embolisation. J Cyst Fibros. 2022; :. doi: 10.1016/j.jcf.2022.04.015. PubMed PMID:35508453 .

Search PubMed

Dernières Publications (10/268)

Frandon, J, Belaouni, A, Pellerin, O, Thiounn, N, Serrand, C, Droupy, S et al.. Efficacy and safety of prostate artery embolization for patients with lower urinary tract symptoms and indwelling urinary catheter: A retrospective multicenter study. Diagn Interv Imaging. 2022; :. doi: 10.1016/j.diii.2022.07.002. PubMed PMID:35963778 .
Tatiana, H, Elsa, K, Eric, G. [¹⁸F]FDG brain PET findings in CLIPPERS at diagnosis and therapeutic follow-up. Eur J Nucl Med Mol Imaging. 2022; :. doi: 10.1007/s00259-022-05939-x. PubMed PMID:35962144 .
Verger, A, Barthel, H, Tolboom, N, Fraioli, F, Cecchin, D, Albert, NL et al.. 2-[¹⁸F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee. Eur J Nucl Med Mol Imaging. 2022; :. doi: 10.1007/s00259-022-05913-7. PubMed PMID:35840817 PubMed Central PMC9286958.
Panneau, J, Mege, D, Biseglie, MD, Duclos, J, Habert, P, Vidal, V et al.. Emborrhoid: Rectal Artery Embolization for Hemorrhoid Disease. Semin Intervent Radiol. 2022;39 (2):194-202. doi: 10.1055/s-0042-1745800. PubMed PMID:35781988 PubMed Central PMC9246490.
Bec, R, Reynaud-Gaubert, M, Arnaud, F, Naud, R, Dufeu, N, Di Bisceglie, M et al.. Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: Early report. Eur J Radiol. 2022;154 :110421. doi: 10.1016/j.ejrad.2022.110421. PubMed PMID:35772339 .
Goren, S, Paladino, NC, Laks, S, Cuny, T, Vaillant-Lombard, J, Mennetrey, C et al.. Diagnostic Rechallenge with ¹⁸F-FCH PET/CT Often Allows Minimally Invasive Parathyroidectomy While Maintaining Exceptional Cure Rates. World J Surg. 2022; :. doi: 10.1007/s00268-022-06629-3. PubMed PMID:35763102 .
Nail, V, Louis, B, Moyon, A, Chabert, A, Balasse, L, Fernandez, S et al.. Sublingual Atropine Administration as a Tool to Decrease Salivary Glands’ PSMA-Ligand Uptake: A Preclinical Proof of Concept Study Using [⁶⁸Ga]Ga-PSMA-11. Pharmaceutics. 2022;14 (6):. doi: 10.3390/pharmaceutics14061276. PubMed PMID:35745848 PubMed Central PMC9230580.
Thiery, L, Carle, X, Testud, B, Boulouis, G, Habert, P, Tradi, F et al.. Distal cerebral vasospasm treatment following aneurysmal subarachnoid hemorrhage using the Comaneci device: technical feasibility and single-center preliminary results. J Neurointerv Surg. 2022; :. doi: 10.1136/neurintsurg-2022-018699. PubMed PMID:35584908 .
Soncin, LD, Faure, S, McGonigal, A, Horowitz, T, Belquaid, S, Bartolomei, F et al.. Correlation between fluorodeoxyglucose positron emission tomography brain hypometabolism and posttraumatic stress disorder symptoms in temporal lobe epilepsy. Epilepsia. 2022;63 (7):e74-e79. doi: 10.1111/epi.17300. PubMed PMID:35569022 .
Habert, P, Puech, B, Coiffard, B, Secq, V, Thomas, P, Bec, R et al.. Angiographic and histopathological study on bronchial-to-pulmonary vascular anastomoses on explants from patients with cystic fibrosis after bronchial artery embolisation. J Cyst Fibros. 2022; :. doi: 10.1016/j.jcf.2022.04.015. PubMed PMID:35508453 .

Search PubMed

Recent News

CERIMED OBTAINS DUAL ISO 9001:2015 AND NF X50-900:2016 CERTIFICATION FOR ITS PRE-CLINICAL RADIOLOGICAL AND NUCLEAR SERVICE AND INNOVATION ACTIVITIES

Symposium’21 Program“Innovative drugs & health products, imaging & theranostics agents – cell & gene biotherapies”

VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents

FAIR-Embo hopes to spread safe, cheap embolization around the world

Last Publications (10/268)

Dernières Publications (10/268)

Symposium’21 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”